There were 2,428 press releases posted in the last 24 hours and 441,478 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Plus Therapeutics Reports ReSPECT-LM Phase 1 Trial Data at the 2023 SNO/ASCO CNS Cancer Conference

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image